The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
Open accessAbstract
The cuprizone mouse model allows the investigation of the complex molecular mechanisms behind nonautoimmune-mediated demyelination and spontaneous remyelination. While it is generally accepted that oligodendrocytes are specifically vulnerable to cuprizone intoxication due to their high metabolic demands, a comprehensive overview of the etiology of cuprizone-induced pathology is still missing to date. In this review we extensively describe the physico-chemical mode of action of cuprizone and discuss the molecular and enzymatic mechanisms by which cuprizone induces metabolic stress, oligodendrocyte apoptosis, myelin degeneration and eventually axonal and neuronal pathology. In addition, we describe the dual effector function of the immune system which tightly controls demyelination by effective induction of oligodendrocyte apoptosis, but in contrast also paves the way for fast and efficient remyelination by the secretion of neurotrophic factors and the clearance of cellular and myelinic debris. Finally, we discuss the many clinical symptoms that can be observed following cuprizone treatment, and how these strengthened the cuprizone model as a useful tool to study human multiple sclerosis, schizophrenia and epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly this apoptosis precedes the massive demyelination caused by cuprizone administration [18], indicating that oligodendrocyte degeneration is the main cause, as opposed to a secondary immune response.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“In addition to the direct effect of cuprizone on oligodendrocytes, the involvement of the brain’s resident neuroinflammatory cells such as microglia and astrocyes is also believed to be responsible for the massive demyelination occurring at 4 weeks time point of cuprizone exposure [18].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Nevertheless, a consensus seems to be that cuprizone selectively affects oligodendrocytes.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Astrocytes and microglia collaborate through the release of cytokines, chemokines, and other, yet to be identified factors, to drive demyelination [79, 107], preventing the release of specific cytokines or chemokines, restricting astrocyte reactivity, or ablating microglia all reduce cuprizone-induced demyelination [107, 181, 189, 243].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [107]
In the citing paper
“The cuprizone model is based on oral ingestion of the copper chelator cuprizone, causing metabolic oligodendrocyte injury.”
From Insights and challenges on animal models for progressive multiple sclerosis (2026) · cites this paper as [183]
In the citing paper
“These include cuprizone (CUP), a chemical toxin, which when provided in the diet of adult mice results in reliable demyelination of the corpus callosum (CC). Upon removal of CUP from the diet, there is robust remyelination (Matsushima & Morrell, 2001; Praet, et al, 2014; Wergeland, Torkildsen, Myhr, Mørk, & Bø et al, 2012).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Praet, et al, 2014
In the citing paper
“In the following chapter we will briefly introduce the cuprizone model, a toxin-induced demyelination model [21,22].”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Oral intoxication with the copper-chelator cuprizone induces oligodendrocyte apoptosis within a few days, which is closely followed by the activation of the innate immune cells in the brain, i.e., astrocytes and microglia, finally leading to demyelination of distinct white and grey matter brain areas.”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Mitochondrial injury and oxidative stress are believed to be fundamental elements of CPZ induced pathology (66).”
From Absence of miRNA-146a Differentially Alters Microglia Function and Proteome (2020) · cites this paper as [66]
Citations
Cites
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,588
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Cited by
Sorted by citations
Items 201–300 of 435
Hashem, M., Shafqat, Q., Wu, Y., Rho, J. M., & Dunn, J. F. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.118935 · Cited by 19
Zhang, J., Yang, L., Fang, Z., Kong, J., Huang, Q., & Xu, H. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9799-0 · Cited by 16
Effects of aging on the myelination of the optic nerve in rats
Attia, H., Taha, M., & Abdellatif, A. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1529670 · Cited by 16
Zha, Z., Liu, Y.-J., Liu, S., Zhang, N., Li, J.-L., Qi, F., Jin, L.-Y., Xue, B., Yang, T., Fan, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3800004 · Cited by 15
Hilton, J. B. W., Kysenius, K., Liddell, J. R., Mercer, S. W., Hare, D. J., Buncic, G., Paul, B. T., Wang, Y., Murray, S. S., Kilpatrick, T. J., et al. (2024) · Metallomics · doi:10.1093/mtomcs/mfad072 · Cited by 15
Titus, H. E., Xu, H., Robinson, A. P., Patel, P. A., Chen, Y., Fantini, D., Eaton, V. L., Karl, M. T., Garrison, E. D., Rose, I. V. L., et al. (2022) · Glia · doi:10.1002/glia.24231 · Cited by 14
Fouad, G. I., Mabrouk, M., El‐Sayed, S. A. M., Abdelhameed, M. F., Rizk, M. Z., & Beherei, H. H. (2024) · BioMetals · doi:10.1007/s10534-024-00648-4 · Cited by 15
Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis
Simões-Abade, M. B. C., Patterer, M., Nicaise, A. M., & Pluchino, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1488691 · Cited by 14
Zou, Z., Sun, J., Zheng, K., Wang, Y., Zhao, H., Zhu, K., & Wang, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3205176 · Cited by 14
Interleukin 4 Affects Epilepsy by Regulating Glial Cells: Potential and Possible Mechanism
Chen, L., Zhu, L., Lu, D., Wu, Z., Han, Y., Xu, P., Chang, L., & Wu, Q. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.554547 · Cited by 16
Characterizing microglial gene expression in a model of secondary progressive multiple sclerosis
Vainchtein, I. D., Alsema, A. M., Dubbelaar, M. L., Grit, C., Vinet, J., van Weering, H. R. J., Al‐Izki, S., Biagini, G., Brouwer, N., Amor, S., et al. (2022) · Glia · doi:10.1002/glia.24297 · Cited by 13
Samy, D. M., Zaki, E. I., Hassaan, P. S., Abdelmonsif, D. A., Mohamed, D. Y., & Saleh, S. R. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00959-z · Cited by 15
Mi, G., Wang, Y., Ye, E., Gao, Y., Liu, Q., Chen, P., Zhu, Y., Yang, H., & Yang, Z. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.001 · Cited by 14
Wang, S., Bi, H.-Z., Chu, S., Dong, Y.-X., He, W., Tian, Y., Zang, Y., Zhang, D., Zhang, Z., & Chen, N. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.017 · Cited by 14
Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice
Behrangi, N., Lorenz, P., & Kipp, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01771-w · Cited by 14
Labunets, І. F., Rodnichenko, A. E., Savosko, S. I., & Pivneva, T. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1131130 · Cited by 15
Guglielmetti, C., Cordano, C., Najac, C., Green, A., & Chaumeil, M. M. (2023) · Communications Medicine · doi:10.1038/s43856-023-00300-1 · Cited by 13
Self-citationSajrawi, C., Odeh, M., Tiwari, A. K., Agranovich, B., Abramovich, I., Zubedat, S., Saar, G., Shaulov, L., Avital, A., Reznik, D., et al. (2024) · Glia · doi:10.1002/glia.24624 · Cited by 13
Probenecid-treatment reduces demyelination induced by cuprizone feeding
Hainz, N., Becker, P., Rapp, D., Wagenpfeil, S., Wonnenberg, B., Beißwenger, C., Tschernig, T., & Meier, C. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.06.003 · Cited by 13
Mirzaie, J., Raoofi, A., Jamalpoor, Z., Nezhadi, A., & Golmohammadi, R. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101750 · Cited by 13
Regulation of DAPK1 by Natural Products: An Important Target in Treatment of Stroke
Noori, T., Shirooie, S., Sureda, A., Sobarzo‐Sánchez, E., Dehpour, A. R., Saldías, M., & Akkol, E. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03628-7 · Cited by 13
Mi, G., Gao, Y., Liu, S., Ye, E., Li, Y., Jin, X., Yang, H., & Yang, Z. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1220458 · Cited by 12
Sun, Z., Gu, H.-S., Chen, X., Zhang, L., Li, X., Zhang, J.-W., & Li, L. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.075 · Cited by 13
Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination
Yamazaki, R., Baba, H., & Yamaguchi, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2413-7 · Cited by 14
Long lasting behavioural effects on cuprizone fed mice after neurotoxicant withdrawal
Tomàs-Roig, J., Torrente, M., Cabré, M., Vilella, E., & Colomina, M. T. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.036 · Cited by 15
Atkinson, K. C., Lee, J. B., Hasselmann, J., Kim, S. H., Drew, A., Soto, J. S., Katzenellenbogen, J. A., Harris, N. G., Obenaus, A., & Tiwari-Woodruff, S. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104501 · Cited by 13
Luo, F., Zhang, Z., Barnett, A., Bellinger, T. J., Turcato, F. C., Schmidt, K., & Luo, Y. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113168 · Cited by 12
Beecken, M., Baumann, L., Vankriekelsvenne, E., Manzhula, K., Greiner, T., Heinig, L., Schauerte, S., Kipp, M., & Joost, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310564 · Cited by 14
El-Sayed, S. A. M., Fouad, G., Rizk, M., Beherei, H., & Mabrouk, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04415-x · Cited by 13
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Luo, F., Zhang, Z., & Luo, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312811 · Cited by 12
Almuslehi, M. S. M., Sen, M. K., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01997-w · Cited by 12
Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma
Polyák, H., Cseh, E. K., Bohár, Z., Rajda, C., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06124 · Cited by 14
Chaudhary, R., Albrecht, S., Datunashvili, M., Cerina, M., Lüttjohann, A., Han, Y. S., Narayanan, V., Chetkovich, D. M., Ruck, T., Kuhlmann, T., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab491 · Cited by 13
Acute but not inherited demyelination in mouse models leads to brain tissue stiffness changesPreprint
Eberle, D., Fodelianaki, G., Kurth, T., Jagielska, A., Möllmert, S., Ulbricht, E., Wagner, K., Taubenberger, A. V., Träber, N., Escolano, J.-C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/449603 · Cited by 12
Brain Stiffness Follows Cuprizone-Induced Variations in Local Myelin Content
Zhang, X., & Weickenmeier, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.08.033 · Cited by 11
Multiple sclerosis and infection: history, EBV, and the search for mechanism
SoRelle, E. D., & Luftig, M. A. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00119-23 · Cited by 12
Protective effects of cannabidiol on cuprizone-induced demyelination in C57BL/6 mice
Sajjadian, M., Kashani, I. R., Pasbakhsh, P., Hassani, M., Omidi, A., Takzare, N., Clarner, T., Beyer, C., & Zendedel, A. (2017) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.09201707 · Cited by 11
Engineered PDGFA-ligand-modified exosomes delivery T3 for demyelinating disease targeted therapy
Wang, L., Liao, B.-Y., Li, Y., Wang, Z., Yu, Y., Li, X., & Zhang, Q. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114730 · Cited by 11
Epilepsy and demyelination: Towards a bidirectional relationship
Li, J., Qi, H., Chen, Y., & Zhu, X. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102588 · Cited by 10
Oyagbemi, A. A., Omóbòwálé, T. O., Ochigbo, G. O., Asenuga, E. R., Ola‐Davies, O. E., Ajibade, T. O., Saba, A. B., & Adedapo, A. A. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1336148 · Cited by 10
Proteomic changes during experimental de- and remyelination in the corpus callosum
Szilagyi, G. T., Nawrocki, A. M., Eros, K., Schmidt, J., Fekete, K., Elkjaer, M. L., Hyrlov, K. H., Larsen, M. R., Illes, Z., & Gallyas, F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230249 · Cited by 8
Avşar, T., Erdem, G. Ç., Terzioğlu, G., & Turanlı, E. T. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2104-88 · Cited by 12
Sobel, R. A., Albertelli, M. A., Hinojoza, J. R., Eaton, M. J., Grimes, K., & Rubenstein, E. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac028 · Cited by 10
Yamanaka, K., Nakamura, K., Shibahara, T., Takashima, M., Takaki, H., Hidaka, M., Komori, M., Yoshikawa, Y., Wakisaka, Y., Ago, T., et al. (2022) · Glia · doi:10.1002/glia.24292 · Cited by 10
Hochstrasser, T., Jiangshan, Z., Rühling, S., Schmitz, C., & Kipp, M. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1459190 · Cited by 10
Fouad, G. I., & Ahmed, K. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110125 · Cited by 9
Lee, M. J., Choi, J. H., Kwon, T. W., Jo, H.-S., Ha, Y., Nah, S.-Y., & Cho, I. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.05.001 · Cited by 9
Ge, X., Xiao, G., Huang, H., Du, J., Tao, Y., Yang, A., Wu, H., Zhang, Z., & Qiu, M. S. (2019) · Glia · doi:10.1002/glia.23633 · Cited by 9
Tanaka, A., Anada, K., Yasue, M., Honda, T., Nakamura, H., & Murayama, T. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120446 · Cited by 10
Psychological stress effects on myelin degradation in the cuprizone‐induced model of demyelination
Meknatkhah, S., Dashti, P. S., Mousavi, M., Zeynali, A. M. H., Ahmadian, S., Karima, S., Saboury, A. A., & Riazi, G. H. (2018) · Neuropathology · doi:10.1111/neup.12522 · Cited by 9
van de Wetering, R., Bibi, R., Biggerstaff, A., Hong, S., Pengelly, B., Prisinzano, T. E., Flamme, A. C. L., & Kivell, B. M. (2024) · Glia · doi:10.1002/glia.24583 · Cited by 8
Serneels, P., Schutter, J. D. D., Groef, L. D., Moons, L., & Bergmans, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00694 · Cited by 9
Lindsay, S. L., McCanney, G. A., Zhan, J., Scheld, M., Smith, R. S., Goodyear, C. S., Yates, E. A., Kipp, M., Turnbull, J. E., & Barnett, S. C. (2023) · Glia · doi:10.1002/glia.24363 · Cited by 9
Mather, M. L., Jeffries, M. A., & Wood, T. L. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102193 · Cited by 8
Ghobadi, M., Arji, B., Yadegari, M., Esmailidehaj, M., Moghadam, F. H., & Rezvani, M. E. (2022) · PubMed Central · doi:10.22074/cellj.2022.8261 · Cited by 8
Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments
Flamme, A. C. L., & Orian, J. M. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-25543-9 · Cited by 7
Graetz, C., Groppa, S., Zipp, F., & Siller, N. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1438190 · Cited by 8
Labunets, І. F. (2018) · Ukrainian Neurological Journal · doi:10.30978/unz2018263 · Cited by 8
Kim, W., Hahn, K. R., Jung, H. Y., Kwon, H. J., Nam, S. M., Kim, T. H., Kim, J. W., Yoo, D. Y., Kim, D. W., Choi, J. H., et al. (2020) · Cells · doi:10.3390/cells9061438 · Cited by 8
Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis
Maramai, S., & Brindisi, M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000310 · Cited by 8
Liu, S., Zha, Z., Li, C., Li, C., & Wang, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119283 · Cited by 8
Abdelalim, L. R., Elnaggar, Y. S. R., & Abdallah, O. Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134144 · Cited by 9
Zebrafish as a Model for Multiple Sclerosis
Maktabi, B., Collins, A. R., Safee, R., Bouyer, J., Wisner, A. S., Williams, F. E., & Schiefer, I. T. (2024) · Biomedicines · doi:10.3390/biomedicines12102354 · Cited by 7
Investigation of Cuprizone Inactivation by Temperature
Heckers, S., Held, N., Kronenberg, J., Skripuletz, T., Bleich, A., Gudi, V., & Stangel, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9704-2 · Cited by 7
Vega-Riquer, J. M., Campos-Ordoñez, T., Gálvez‐Contreras, A. Y., González-Castañeda, R. E., & González-Pérez, Ó. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06356-0 · Cited by 7
An in vivo accelerated developmental myelination model for testing promyelinating therapeutics
Lariosa-Willingham, K. D., Leonoudakis, D., Bragge, T., Tolppanen, L., Nurmi, A., Flanagan, M., Gibson, J., Wilson, D. L., Stratton, J., Lehtimäki, K. K., et al. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00714-y · Cited by 7
Yamashina, K., Yamamoto, S., Matsumoto, M., Iwasa, K., Takeda, N., Haruta, C., Maruyama, K., Shimizu, K., & Yoshikawa, K. (2022) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2022044840 · Cited by 7
Labunets, І. F., Rodnichenko, A. E., Melnyk, N. O., Rymar, S. E., Utko, N. A., Gavrulyk-Skyba, G. O., & Butenko, G. M. (2018) · Biopolymers and Cell · doi:10.7124/bc.000989 · Cited by 7
Ma, C., Wu, Y., Liu, X., He, Y., Jia, Y., Chen, P., Yin, D., Ning, Y., Xing, G., Sun, Z., et al. (2021) · Neural Plasticity · doi:10.1155/2021/8812362 · Cited by 7
Ouaamari, Y. E., Ricciardi, L., van der Heijden, S., Peter, A., Waele, J. D., den Bos, J. V., Dam, D. V., Calus, E., Kuhn, S., Marei, W. F. A., et al. (2025) · Glia · doi:10.1002/glia.70058 · Cited by 8
Self-citationWang, Q., Wang, Z., Li, Y., Wang, Q., Chen, Y., Xu, B., & Xu, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1659631 · Cited by 6
Li, Y., Noto, D., Hoshino, Y., Mizuno, M., Yoshikawa, S., & Miyake, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-36532-3 · Cited by 6
Wang, M., Gu, C., Yang, Y., Chen, L., Chen, K., Du, J. B., Wu, H., & Li, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1269862 · Cited by 6
New Insight into the Possible Roles of L-Carnitine in a Rat Model of Multiple Sclerosis
Safwat, S. M., Aboonq, M. S., Tohamy, M. E., Mojaddidi, M. A., Alqahtani, S. A. M., Zakari, M. O., ElGendy, A. A., & Hussein, A. M. (2023) · Brain Sciences · doi:10.3390/brainsci14010023 · Cited by 6
Mwema, A., Gratpain, V., Učakar, B., Vanvarenberg, K., Perdaens, O., Pesch, V. V., Muccioli, G. G., & Rieux, A. D. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01535-8 · Cited by 6
Gopalasingam, G., Bartlett, C. A., McGonigle, T. A., Majimbi, M., Warnock, A., Ford, A., Gough, A., Toomey, L. M., & Fitzgerald, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.06.005 · Cited by 7
What Can We Learn from Animal Models to Study Schizophrenia?
Crunfli, F., Brandão‐Teles, C., Zuccoli, G. S., Filho, A. J. M. C., Vieira, G. M., Silva-Amaral, D., Crippa, J. A. S., Pedrazzi, J. F. C., Macêdo, D. S., Bel, E. A. D., et al. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_2 · Cited by 7
Rowhanirad, S., & Taherianfard, M. (2023) · Brain and Behavior · doi:10.1002/brb3.3144 · Cited by 6
Omotoso, G. O., Arietarhire, L. O., Inelo, U. I., & Gbadamosi, I. (2018) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.300 · Cited by 7
Labunets, І. F., Utko, N. A., Toporova, O. K., Savosko, S. I., Pokholenko, I., Panteleymonova, T. N., & Butenko, G. M. (2021) · Biopolymers and Cell · doi:10.7124/bc.000a62 · Cited by 6
Synthesis and structural characterization of copper–cuprizone complexes
Pushie, M. J., Summers, K. L., Nienaber, K. H., Pickering, I. J., & George, G. N. (2022) · Dalton Transactions · doi:10.1039/d2dt01475k · Cited by 6
Rodnichenko, A. E., & Labunets, І. F. (2018) · Cell and Organ Transplantology · doi:10.22494/cot.v6i2.90 · Cited by 6
Kanhai, K., Zuiker, R., Houghton, W. H., Kramer, W. G., McBride, K., Moerland, M., Dorfman, A., McGlothlin, M., Hotchkin, M. T., Mortenson, M. G., et al. (2023) · medRxiv · doi:10.1101/2023.05.11.23289871 · Cited by 6
Jansen, M. I., Mahmood, Y., Lee, J. J., Broome, S. T., Waschek, J. A., & Castorina, A. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16199 · Cited by 5
MAZ regulates ferroptosis, apoptosis and differentiation of oligodendrocyte precursor cells
Jing, F., Wang, Q., Xu, Y., Dong, J., Huang, H., & Li, Y. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149349 · Cited by 5
Lohrberg, M., Mortensen, L. S., Thomas, C., Fries, F., van der Meer, F., Götz, A. A., Landt, C., Rhee, H. J., Rhee, J., Gómez‐Varela, D., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03368-9 · Cited by 5
Liu, L., Zhao, Y., Bu, J., Peng, S., Li, Y., Su, P., & Li, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114592 · Cited by 5
Melatonin Effects in Young and Aging Mice with the Toxic Cuprizone-Induced Demyelination
Labunets, І. F., & Rodnichenko, A. E. (2020) · Advances in Gerontology · doi:10.1134/s2079057020010105 · Cited by 5
Fouad, G. I., Mabrouk, M., El‐Sayed, S. A. M., Rizk, M. Z., & Beherei, H. H. (2023) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2023.2177219 · Cited by 5
Fu, J., Yang, C.-J., Lee, L., Chen, W.-P., Chen, Y., Chen, C., Sun, Y., Yang, C., & Tzeng, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116297 · Cited by 6
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A., de Almeida, V., & Martins‐de‐Souza, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.673144 · Cited by 5
Mohammadi, M., Abdi, M., Alidadi, M., Mohamed, W. M. Y., Zibara, K., & Kashani, I. R. (2021) · PubMed Central · Cited by 5
Hahn, K. R., Kwon, H. J., Kim, W., Jung, H. Y., Hwang, I. K., Kim, D. W., & Yoon, Y. S. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03886-z · Cited by 5
Meknatkhah, S., Dashti, P. S., Raminfard, S., Rad, H. S., Mousavi, M., & Riazi, G. H. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01702-9 · Cited by 5
Safaei, H. A., Eftekhari, S. M., & Aliomrani, M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00802-8 · Cited by 5
A comparative transcriptomic analysis of mouse demyelination models and multiple sclerosis lesions
Aboelnour, E. L., Vanoverbeke, V. R., Maupin, E. A., Hatfield, M. M., & Adams, K. L. (2026) · Nature Communications · doi:10.1038/s41467-026-72383-y · Cited by 4
Alam, M. Z., Bagabir, H. A., Zaher, M. A. F., Alqurashi, T. M. A., Alghamdi, B. S. A., Kazi, M., Suhail, M., Alshahrany, G. A., Alzahrani, N. A., Bakhalgi, R. M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1633855 · Cited by 4
Moussaoui, H., Ladjel‐Mendil, A., & Laraba‐Djebari, F. (2022) · Toxin Reviews · doi:10.1080/15569543.2021.2022698 · Cited by 4
Labunets, І. F., Panteleymonova, T., Kyryk, V. M., Toporova, O. K., & Litoshenko, Z. (2023) · Cell and Organ Transplantology · doi:10.22494/cot.v11i2.155 · Cited by 4
Metadata
- Authors
- Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P.
- Affiliations
- University of Antwerp (BE)
- Corresponding author
- Praet, Jelle
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 47
- Pages
- 485-505
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1991883207
- Cited by
- 435
- References
- 268
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 29 · 2023: 37 · 2022: 51 · 2021: 49 · 2020: 48 · 2019: 49 · 2018: 41 · 2017: 35 · 2016: 19 · 2015: 12
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fund for Scientific Research-Flanders
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- cuprizone, multiple sclerosis, demyelination, remyelination, oligodendrocyte apoptosis, myelin degeneration, metabolic stress, neuroinflammation, neurotrophic factors, myelin debris clearance, axonal pathology, neuronal pathology, schizophrenia, epilepsy, mouse model
- MeSH terms
- Animals, Brain, Cuprizone, Disease Models, Animal, Multiple Sclerosis, Myelin Sheath, Neuroglia, Neurons, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
